Journal article · 2022 · Open access
Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)
Dermatology and Therapy, 12(6), 1367–1381 · Published 19 May 2022 · DOI 10.1007/s13555-022-00736-8
In brief
“Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)” is a 2022 journal article by Arthur David Burden and 7 co-authors, published in Dermatology and Therapy. OpenAlex counts 10 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Dermatology and Therapy.
- Citations
- 10
- Most cited in
- 2025 (5)
- Field-weighted impact
- 0.77
- References
- 12
- Authors
- 8
Abstract
We sought to understand key symptoms of generalized pustular psoriasis (GPP) and to confirm the relevance to patients and content validity of the Psoriasis Symptom Scale (PSS) in GPP. A targeted literature review and clinical expert interviews were conducted as background research. Patients were interviewed individually (involving concept elicitation and cognitive interviews), and a separate patient workshop was conducted to determine disease-specific symptoms of importance. Seven participants with moderate (n = 4), severe (n = 2), and mild (n = 1) GPP and clinician diagnosis were interviewed. During concept elicitation, all participants indicated that pustules may underlie other symptoms. Symptoms reported by all patients were pain, redness, itch, burning, and discomfort. The PSS symptoms of pain, itching, burning, and redness were reported by ≥ 86% of patients as most frequently experienced. Upon debriefing, the PSS was well understood. Relevance and importance of these symptoms was confirmed in the GPP patient workshop. Participant feedback found the PSS measure to be relevant and easy to understand. The symptoms included in the instrument, pain, redness, itch, and burning, were most frequently reported, important, and well understood by patients. Study results provided support for the content validity of the PSS for use as endpoints in GPP clinical trials. Generalized pustular psoriasis (GPP) is a severe rare disease, including redness and boils that sometimes come with fever and other general symptoms. This study asked patients with GPP about their key symptoms, and whether the Psoriasis Symptom Scale (PSS) is relevant to them as patients. The PSS is a questionnaire with the symptoms pain, itching, burning, and redness. We searched the literature and interviewed clinical experts to guide the patient interviews. Patients were recruited through clinical sites and the National Psoriasis Foundation (NPF). The interviews discussed GPP symptoms and the PSS questionnaire. Patients with GPP were also asked about commonly experienced symptoms in a workshop. Most patients had moderate to severe GPP. Patients in both the interviews and workshop described experiencing pain, redness, itch, burning, and discomfort with their boils. During interviews, the patients said the PSS questionnaire was easy to understand. Patients in the workshop also found the PSS to be relevant and easy to understand. Patients agreed the symptoms in the PSS, pain, redness, itch, and burning, were common and important. Study results support the PSS for use with patients in clinical trials.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Burden, A. D., Mrowietz, U., Skalicky, A. M., Rentz, A. M., Esser, D., Gloede, T., Thoma, C., & Menter, A. (2022). Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP). Dermatology and Therapy, 12(6), 1367–1381. https://doi.org/10.1007/s13555-022-00736-8
MLA 9
Burden, Arthur David, et al. “Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP).” Dermatology and Therapy, vol. 12, no. 6, 2022, pp. 1367–1381. https://doi.org/10.1007/s13555-022-00736-8.
Chicago
Burden, Arthur David, Ulrich Mrowietz, Anne M. Skalicky, Anne M. Rentz, Dirk Esser, Tristan Gloede, Christian Thoma, and Alan Menter. 2022. “Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP).” Dermatology and Therapy 12 (6): 1367–1381. https://doi.org/10.1007/s13555-022-00736-8.
Harvard
Burden, A. D. et al. (2022) ‘Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)’, Dermatology and Therapy, 12(6), pp. 1367–1381. doi:10.1007/s13555-022-00736-8.
IEEE
A. D. Burden et al., “Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP),” Dermatology and Therapy, vol. 12, no. 6, pp. 1367–1381, 2022, doi: 10.1007/s13555-022-00736-8.
BibTeX
@article{burden2022symptom,
title = {{Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)}},
author = {Burden, Arthur David and Mrowietz, Ulrich and Skalicky, Anne M. and Rentz, Anne M. and Esser, Dirk and Gloede, Tristan and Thoma, Christian and Menter, Alan},
journal = {Dermatology and Therapy},
year = {2022},
volume = {12},
number = {6},
pages = {1367--1381},
doi = {10.1007/s13555-022-00736-8},
url = {https://doi.org/10.1007/s13555-022-00736-8}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 2 | |
| 2024 | 2 | |
| 2025 | 5 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.77: it has been cited 0.77 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- generalized pustular psoriasis
- symptom experience
- content validity
- patient-reported outcomes
- pain
- pruritus
- burning
- redness
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Burden, A. D., Mrowietz, U., Skalicky, A. M., Rentz, A. M., Esser, D., Gloede, T., Thoma, C., & Menter, A. (2022). Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP). Dermatology and Therapy, 12(6), 1367–1381. https://doi.org/10.1007/s13555-022-00736-8
How many times has this paper been cited?
10 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Dermatology and Therapy: sign in and open the PDF from this page.
Who wrote this paper?
Arthur David Burden, Ulrich Mrowietz, Anne M. Skalicky, Anne M. Rentz, Dirk Esser, Tristan Gloede, Christian Thoma, Alan Menter.
What is the DOI of this paper?
10.1007/s13555-022-00736-8, permanently at https://doi.org/10.1007/s13555-022-00736-8. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.